Kinnari Patel - 20 May 2025 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Reporting relationship: President, Head of R&D and Chief Operating Officer
Issuer ticker: RCKT
Reported as of: 20 May 2025
Net transaction value: -$4,944
SEC form: 4
Accepted by SEC: 22 May 2025, 16:05:43 UTC
Prior SEC filing: 20 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Martin Wilson, as attorney-in-fact for Kinnari Patel

Key filing fact

Kinnari Patel filed Form 4 for ROCKET PHARMACEUTICALS, INC. (RCKT) on 22 May 2025.

Key facts

This page summarizes Kinnari Patel's Form 4 filing for ROCKET PHARMACEUTICALS, INC. (RCKT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 May 2025, 16:05.

Change

Previous filing in this sequence was filed on 20 May 2025.
Current net transaction value: -$4,944.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001725929 Primary reporting owner

Patel Kinnari

Relationship: President, Head of R&D and Chief Operating Officer
Address: C/O ROCKET PHARMACEUTICALS, INC., 9 CEDARBROOK DRIVE, CRANBURY
Signature: /s/ Martin Wilson, as attorney-in-fact for Kinnari Patel
Signature date: 22 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RCKT transaction

Common Stock

Sale

Transaction value: $4,944
Shares: -767
Change %: -0.17%
Price: $6.45
Shares after: 441,927
Date: 20 May 2025
Ownership: Direct
Footnotes: F1, F2

RCKT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 26,774
Date: 20 May 2025
Ownership: By Spouse

RCKT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 104,927
Date: 20 May 2025
Ownership: By Adaptive Technology LLC
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.

Footnote F2

The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.

Footnote F3

The shares are held indirectly through Adaptive Technology, LLC, a limited liability company that is owned and managed by the reporting person's husband.

SEC remarks

President, Head of R&D and Chief Operating Officer